News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:
   

Epizyme (EPZM) Struts Back To Wall Street, Plans $140 Million Raise



1/27/2014 8:06:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Epizyme saw its stock jump up a few weeks ago after hitting a milestone in its big partnership with Celgene. Now it plans to use some of that momentum to raise some more cash from public investors. On Monday morning, Cambridge, MA-based Epizyme (NASDAQ: EPZM) filed papers with the Securities and Exchange Commission showing it plans to raise as much as $140 million in cash through a public offering of stock.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy


comments powered by Disqus
Xconomy
Epizyme
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES